Financials
- Market Capitalization 167.31 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.38
Relación precio/flujo de caja
18.82
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3724 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.62 USD | -5.24% | -7.89% | 0.00% | +88.54% | 171.54 M USD | ||
| 3731 | TLSA Tiziana Life Sciences Ltd - Common Shares | 1.23 USD | -7.52% | -2.38% | +6.03% | -15.75% | 148.22 M USD | ||
| 3736 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.78 USD | +5.05% | +11.16% | +0.84% | +342.59% | 172.16 M USD | ||
| 3744 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.80 USD | +0.56% | -4.76% | -0.55% | +5.26% | 168.69 M USD |